[18F]FDG-PET/CT对风湿性多肌痛诊断价值的系统评价与荟萃分析
该系统评价与荟萃分析检索了PubMed/MEDLINE和Cochrane图书馆至2020年5月31日的文献,纳入20项研究,其中9项(n=636例患者)进入荟萃分析。结果显示,棘间滑囊、髋、坐骨结节、肩和胸锁关节的[18F]FDG阳性与风湿性多肌痛诊断相关,复合评分汇总阳性似然比为3.91、阴性似然比为0.19。结论认为[18F]FDG-PET/CT可能是疑似风湿性多肌痛患者的重要诊断工具,并强调需遵循操作推荐和标准化判读标准。
要点
- 棘间滑囊、髋、坐骨结节、肩和胸锁关节[18F]FDG阳性与风湿性多肌痛诊断相关。
- 复合[18F]FDG-PET/CT评分汇总阳性似然比3.91、阴性似然比0.19。
- 研究间存在中高度异质性,主要源于患者选择、扫描流程和判读标准差异。
核心结论
- 多个解剖部位组合的显著[18F]FDG摄取对风湿性多肌痛诊断具有信息价值。
- [18F]FDG-PET/CT可能是疑似风湿性多肌痛患者的重要诊断工具。
- 研究强调需遵循已发表的操作推荐和标准化判读标准。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed/MEDLINE和Cochrane图书馆数据库自建库至2020年5月31日。
- 纳入20项研究进行系统评价,其中9项(n=636例患者)符合荟萃分析条件。
- 由3名研究者进行筛选和全文审查,2名研究者提取数据,采用QUADAS-2工具评估偏倚风险。
- 诊断试验荟萃分析采用双变量模型。
主要发现
- 棘间滑囊[18F]FDG阳性与风湿性多肌痛诊断相关,阳性似然比4.00(95%CI 1.84-8.71)。
- 髋部[18F]FDG阳性阳性似然比2.91(95%CI 2.09-4.05),坐骨结节2.86(95%CI 1.91-4.28)。
- 肩部[18F]FDG阳性阳性似然比2.57(95%CI 1.24-5.32),胸锁关节2.31(95%CI 1.33-4.02)。
- 上述部位及大转子的阴性似然比均小于0.50。
- 3项研究报告的复合[18F]FDG-PET/CT评分汇总阳性似然比3.91(95%CI 2.42-6.32),阴性似然比0.19(95%CI 0.10-0.36)。
关键数值与推荐
- 棘间滑囊阳性似然比4.00(95%CI 1.84-8.71)。
- 髋部阳性似然比2.91(95%CI 2.09-4.05)。
- 坐骨结节阳性似然比2.86(95%CI 1.91-4.28)。
- 肩部阳性似然比2.57(95%CI 1.24-5.32)。
- 胸锁关节阳性似然比2.31(95%CI 1.33-4.02)。
临床怎么用
- 对疑似风湿性多肌痛患者,可关注棘间滑囊、髋、坐骨结节、肩和胸锁关节的[18F]FDG摄取。
- 复合[18F]FDG-PET/CT评分阴性似然比0.19,有助于降低临床怀疑度。
- 应用[18F]FDG-PET/CT诊断风湿性多肌痛时应遵循已发表的操作推荐和标准化判读标准。
局限性
- 研究间存在中高度异质性,主要由于患者选择、扫描流程和/或判读标准差异。
- 仅9项研究(n=636例患者)进入荟萃分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Polymyalgia rheumatica (PMR) can be difficult to diagnose. Whole-body [18F]FDG-PET/CT allows for a comprehensive evaluation of all relevant articular and extra-articular structures affected by PMR. We aimed to summarize current evidence on the diagnostic value of [18F]FDG-PET/CT for a diagnosis of PMR. METHODS: PubMed/MEDLINE and the Cochrane Library database were searched from inception through May 31, 2020. Studies containing patients with PMR who underwent [18F]FDG-PET/CT were included. Screening and full-text review were performed by 3 investigators and data extraction by 2 investigators. Risk of bias was examined with the QUADAS-2 tool. Diagnostic test meta-analysis was performed with a bivariate model. RESULTS: Twenty studies were included in the systematic review, of which 9 studies (n = 636 patients) were eligible for meta-analysis. [18F]FDG positivity at the following sites was associated with a diagnosis of PMR: interspinous bursae (positive likelihood ratio (LR+) 4.00; 95% CI 1.84-8.71), hips (LR+ 2.91; 95% CI 2.09-4.05), ischial tuberosities (LR+ 2.86; 95% CI 1.91-4.28), shoulders (LR+ 2.57; 95% CI 1.24-5.32) and sternoclavicular joints (LR+ 2.31; 95% CI 1.33-4.02). Negative likelihood ratios (LR-) for these sites, as well as the greater trochanters, were all less than 0.50. Composite [18F]FDG-PET/CT scores, as reported in 3 studies, provided a pooled LR+ of 3.91 (95% CI 2.42-6.32) and LR- of 0.19 (95% CI 0.10-0.36). Moderate to high heterogeneity was observed across the studies, mainly due to differences in patient selection, scanning procedures and/or interpretation criteria. CONCLUSION: Significant [18F]FDG uptake at a combination of anatomic sites is informative for a diagnosis of PMR. [18F]FDG-PET/CT might be an important diagnostic tool in patients with suspected PMR. This study also highlights the need for adherence to published procedural recommendations and standardized interpretation criteria for the use of [18F]FDG-PET/CT in PMR.
引用
- van der Geest KSM, Treglia G, Glaudemans AWJM, et al. Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2020. PMID: 33372248. doi:10.1007/s00259-020-05162-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。